There has been considerable publicity surrounding the potential benefits of herceptin in treating early breast cancer and whether or not its benefits outweigh the costs of treatment. In this article, requested by visitors to the www.behindthemedicalheadlines.com site, Dr David Cameron provides an overview of the development of herceptin, its use in treatment and its safety profile.
